JANUET 50/850 MG TABLETS

Pays: Israël

Langue: anglais

Source: Ministry of Health

Ingrédients actifs:

METFORMIN HYDROCHLORIDE 850 MG; SITAGLIPTIN AS MONOHYDRATE PHOSPHATE 50 MG

Disponible depuis:

MERCK SHARP & DOHME ISRAEL LTD

Code ATC:

A10BA02

forme pharmaceutique:

TABLETS

Mode d'administration:

PER OS

Fabriqué par:

MERCK SHARP & DOHME CORP., USA

Groupe thérapeutique:

METFORMIN

indications thérapeutiques:

Januet is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. Important limitations of use:Januet should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings.Januet has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using Januet.

Date de l'autorisation:

2008-12-01